Skip to content
FDA Advisory Panel Member Discusses Pfizer’s COVID-19 Vaccine For Children 5-11 Years Old

FDA advisory group member discusses Pfizer’s COVID-19 vaccine for children ages 5-11

Watch CBSN Live

An FDA advisory panel is endorsing a reduced-dose version of Pfizer’s COVID-19 vaccine for kids aged 5 to 11. If the FDA and CDC sign off, shots for kids could be available by late next week. CBS News’ Debra Alfarone reports, and then Dr. Stanley Perlman, a member of the FDA panel, joins CBSN’s Tanya Rivero to discuss to vaccine and what it means for children and parents.

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.